Meanwhile, the GG genotype of the MTNR1b (encoding melatonin receptor MT2) gene rs#10830963 polymorphism significantly elevated the risk of breast cancer by about 21 times more than the CC genotype (OR = 20.67; 95% CI = 4.77-99.33) [33]. Here, MTNR1B is linked to breast cancer.